Revenue Summary of Eurofins Scientific SE

Eurofins Scientific SE's latest annual revenue in 2023 was 6.51 Billion EUR , down -2.94% from previous year.
Eurofins Scientific SE's latest quarterly revenue in 2024 Q2 was 1.7 Billion EUR , down 0.0% from previous quarter.
Eurofins Scientific SE reported a annual revenue of 6.71 Billion EUR in annual revenue 2022, down -0.08% from previous year.
Eurofins Scientific SE reported a annual revenue of 6.71 Billion EUR in annual revenue 2021, up 23.51% from previous year.
Eurofins Scientific SE reported a quarterly revenue of 1.7 Billion EUR for 2024 Q1, down -48.28% from previous quarter.
Eurofins Scientific SE reported a quarterly revenue of 1.6 Billion EUR for 2023 Q1, down -51.38% from previous quarter.

Annual Revenue Chart of Eurofins Scientific SE (2023 - 2002)

Historical Annual Revenue of Eurofins Scientific SE (2023 - 2002)

Year	Revenue	Revenue Growth
2023	6.51 Billion EUR	-2.94%
2022	6.71 Billion EUR	-0.08%
2021	6.71 Billion EUR	23.51%
2020	5.43 Billion EUR	19.2%
2019	4.56 Billion EUR	20.67%
2018	3.78 Billion EUR	27.25%
2017	2.97 Billion EUR	17.14%
2016	2.53 Billion EUR	30.08%
2015	1.95 Billion EUR	38.28%
2014	1.41 Billion EUR	15.07%
2013	1.22 Billion EUR	17.4%
2012	1.04 Billion EUR	25.94%
2011	828.93 Million EUR	21.84%
2010	680.33 Million EUR	6.29%
2009	640.07 Million EUR	1.16%
2008	632.75 Million EUR	28.67%
2007	491.77 Million EUR	33.64%
2006	367.99 Million EUR	57.86%
2005	233.1 Million EUR	32.81%
2004	175.51 Million EUR	4.06%
2003	168.67 Million EUR	4.37%
2002	161.6 Million EUR	0.0%

Year	Revenue	Revenue Growth
2024 Q2	1.7 Billion EUR	0.0%
2024 Q1	1.7 Billion EUR	-48.28%
2023 Q1	1.6 Billion EUR	-51.38%
2023 Q3	1.65 Billion EUR	-48.51%
2023 Q2	3.2 Billion EUR	100.0%
2023 Q4	3.3 Billion EUR	100.0%
2023 FY	6.51 Billion EUR	-2.94%
2022 Q3	1.65 Billion EUR	-51.63%
2022 Q4	3.3 Billion EUR	100.0%
2022 FY	6.71 Billion EUR	-0.08%
2022 Q1	1.7 Billion EUR	-50.49%
2022 Q2	3.41 Billion EUR	100.0%
2021 Q4	3.44 Billion EUR	100.0%
2021 Q2	3.27 Billion EUR	100.0%
2021 Q1	1.63 Billion EUR	-47.48%
2021 FY	6.71 Billion EUR	23.51%
2021 Q3	1.72 Billion EUR	-47.36%
2020 FY	5.43 Billion EUR	19.2%
2020 Q1	1.16 Billion EUR	-51.5%
2020 Q3	1.55 Billion EUR	-32.96%
2020 Q2	2.32 Billion EUR	100.0%
2020 Q4	3.11 Billion EUR	100.0%
2019 FY	4.56 Billion EUR	20.67%
2019 Q1	1.08 Billion EUR	6.38%
2019 Q2	2.16 Billion EUR	100.0%
2019 Q3	1.19 Billion EUR	-44.75%
2019 Q4	2.39 Billion EUR	100.0%
2018 Q1	871.65 Million EUR	10.72%
2018 FY	3.78 Billion EUR	27.25%
2018 Q2	871.65 Million EUR	0.0%
2018 Q3	1.01 Billion EUR	16.89%
2018 Q4	1.01 Billion EUR	0.0%
2017 Q3	787.24 Million EUR	12.71%
2017 FY	2.97 Billion EUR	17.14%
2017 Q4	787.24 Million EUR	0.0%
2017 Q1	698.46 Million EUR	5.17%
2017 Q2	698.46 Million EUR	0.0%
2016 Q2	604.19 Million EUR	0.0%
2016 Q1	604.19 Million EUR	9.04%
2016 Q3	664.1 Million EUR	9.92%
2016 Q4	664.1 Million EUR	0.0%
2016 FY	2.53 Billion EUR	30.08%
2015 Q1	420.95 Million EUR	9.81%
2015 Q4	554.08 Million EUR	0.0%
2015 Q3	554.08 Million EUR	31.63%
2015 FY	1.95 Billion EUR	38.28%
2015 Q2	420.95 Million EUR	0.0%
2014 FY	1.41 Billion EUR	15.07%
2014 Q3	383.36 Million EUR	19.15%
2014 Q1	321.75 Million EUR	-1.8%
2014 Q2	321.75 Million EUR	0.0%
2014 Q4	383.36 Million EUR	0.0%
2013 Q1	285.13 Million EUR	1.18%
2013 FY	1.22 Billion EUR	17.4%
2013 Q4	327.65 Million EUR	0.0%
2013 Q3	327.65 Million EUR	14.91%
2013 Q2	285.13 Million EUR	0.0%
2012 Q2	- EUR	-100.0%
2012 Q4	281.79 Million EUR	0.0%
2012 Q3	281.79 Million EUR	0.0%
2012 FY	1.04 Billion EUR	25.94%
2012 Q1	260.99 Million EUR	7.35%
2011 Q3	213.74 Million EUR	2.87%
2011 Q2	207.77 Million EUR	26.46%
2011 Q1	164.3 Million EUR	-67.46%
2011 FY	828.93 Million EUR	21.84%
2011 Q4	243.11 Million EUR	13.74%
2010 FY	680.33 Million EUR	6.29%
2010 Q2	169.44 Million EUR	13.64%
2010 Q1	149.1 Million EUR	-68.74%
2010 Q3	493.97 Million EUR	191.52%
2010 Q4	504.91 Million EUR	2.21%
2009 Q3	468.1 Million EUR	198.59%
2009 Q1	148.24 Million EUR	-6.29%
2009 Q4	476.98 Million EUR	1.9%
2009 Q2	156.77 Million EUR	5.75%
2009 FY	640.07 Million EUR	1.16%
2008 Q4	158.18 Million EUR	0.0%
2008 FY	632.75 Million EUR	28.67%
2008 Q2	158.18 Million EUR	0.0%
2008 Q1	158.18 Million EUR	28.67%
2008 Q3	158.18 Million EUR	0.0%
2007 Q2	122.94 Million EUR	0.0%
2007 Q1	122.94 Million EUR	33.64%
2007 FY	491.77 Million EUR	33.64%
2007 Q4	122.94 Million EUR	0.0%
2007 Q3	122.94 Million EUR	0.0%
2006 Q4	91.99 Million EUR	0.0%
2006 FY	367.99 Million EUR	57.86%
2006 Q2	91.99 Million EUR	0.0%
2006 Q1	91.99 Million EUR	57.86%
2006 Q3	91.99 Million EUR	0.0%
2005 Q2	58.27 Million EUR	0.0%
2005 FY	233.1 Million EUR	32.81%
2005 Q1	58.27 Million EUR	32.81%
2005 Q4	58.27 Million EUR	0.0%
2005 Q3	58.27 Million EUR	0.0%
2004 Q1	43.87 Million EUR	4.06%
2004 Q4	43.87 Million EUR	0.0%
2004 Q2	43.87 Million EUR	0.0%
2004 Q3	43.87 Million EUR	0.0%
2004 FY	175.51 Million EUR	4.06%
2003 Q2	42.16 Million EUR	0.0%
2003 Q4	42.16 Million EUR	0.0%
2003 FY	168.67 Million EUR	4.37%
2003 Q1	42.16 Million EUR	4.37%
2003 Q3	42.16 Million EUR	0.0%
2002 FY	161.6 Million EUR	0.0%
2002 Q2	40.4 Million EUR	0.0%
2002 Q3	40.4 Million EUR	0.0%
2002 Q4	40.4 Million EUR	0.0%
2002 Q1	40.4 Million EUR	0.0%

Peer Revenue Comparison of Eurofins Scientific SE

Name	Revenue	Revenue Difference
Biosynex SA	92.97 Million EUR	-6906.604%
Predilife S.A.	317.79 Thousand EUR	-2049844.304%
bioMérieux S.A.	3.67 Billion EUR	-77.282%
Lumibird SA	203.55 Million EUR	-3100.35%

Global Stocks Search

Eurofins Scientific SE (ERF.PA)

Revenue Summary of Eurofins Scientific SE

Annual Revenue Chart of Eurofins Scientific SE (2023 - 2002)

Historical Annual Revenue of Eurofins Scientific SE (2023 - 2002)

Peer Revenue Comparison of Eurofins Scientific SE